FDA WARNING_LETTER - MGM Cattle Co. LTD - June 08, 2015

On June 4-8, 2015, the FDA inspected MGM Cattle Company, Ltd., identifying significant violations of the Federal Food, Drug, and Cosmetic Act. A cow sold for slaughter on November 30, 2014, was found to be adulterated, containing flunixin (2.32 ppm in liver), desfuroylceftiofur (16.58 ppm in kidney), and florfenicol (0.31 ppm in muscle), exceeding established tolerances (0.125 ppm, 0.4 ppm, and 0.3 ppm respectively). This violates section 402(a)(2)(C)(ii) of the FD&C Act.

The investigation also revealed insanitary conditions, specifically inadequate record-keeping for treated animals. Treatment records prior to December 28, 2014, were not maintained, and subsequent records lacked details on administration routes or withdrawal times, leading to adulteration under section 402(a)(4). Furthermore, the company provided a false guaranty on November 30, 2014, stating livestock sold did not have illegal drug residues, a prohibited act under section 301(h).

The company's June 12, 2015, response was deemed inadequate as it failed to address proper treatment record documentation and a process for drug inventory control to prevent expired products. MGM Cattle